First Time Loading...

Cooper Companies Inc
NYSE:COO

Watchlist Manager
Cooper Companies Inc Logo
Cooper Companies Inc
NYSE:COO
Watchlist
Price: 101.46 USD -0.37% Market Closed
Updated: Mar 29, 2024

Intrinsic Value

The Cooper Cos, Inc. operates as a medical device company. [ Read More ]

The intrinsic value of one COO stock under the Base Case scenario is 55.01 USD. Compared to the current market price of 101.46 USD, Cooper Companies Inc is Overvalued by 46%.

Key Points:
COO Intrinsic Value
Base Case
55.01 USD
Overvaluation 46%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Cooper Companies Inc

Backtest COO Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling COO stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Solid Q1 Results with Optimistic Full Year Guidance
2024-Q1 Earnings Call

Solid Q1 Results with Optimistic Full Year Guidance

The company achieved a strong first quarter with $932 million in revenues, marking a 9% increase from last year. Gross margins rose to 67.3% due to efficiency and pricing strategies, and Non-GAAP EPS surged 18% to $0.85. Despite a modest $5 million in free cash flow due to ongoing capacity expansions, the future looks bright. Revenue expectations have been raised to $3.85 to $3.9 billion for the full year, representing a 7-8% organic increase. CooperVision's revenue guidance is lifted to an 8-9% growth, while CooperSurgical anticipates a 5-7% boost. EPS forecasts are now set at $3.50 to $3.58, a 9-12% improvement from the previous year. The effective tax rate is projected to be about 14.5%, and currency headwinds are expected to have a modest negative impact.

Financials

Balance Sheet Decomposition
Cooper Companies Inc

Current Assets 1.8B
Cash & Short-Term Investments 135.2m
Receivables 651m
Other Current Assets 1B
Non-Current Assets 10.2B
PP&E 1.7B
Intangibles 5.6B
Other Non-Current Assets 2.9B
Current Liabilities 964.9m
Accounts Payable 202.3m
Accrued Liabilities 178.7m
Short-Term Debt 45.1m
Other Current Liabilities 538.8m
Non-Current Liabilities 3.4B
Long-Term Debt 2.7B
Other Non-Current Liabilities 646.4m
Efficiency

Earnings Waterfall
Cooper Companies Inc

Revenue
3.7B USD
Cost of Revenue
-1.2B USD
Gross Profit
2.4B USD
Operating Expenses
-1.9B USD
Operating Income
536.7m USD
Other Expenses
-245.9m USD
Net Income
290.8m USD

Free Cash Flow Analysis
Cooper Companies Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
What is Free Cash Flow?
Fundamental Scores

COO Profitability Score
Profitability Due Diligence

Cooper Companies Inc's profitability score is 58/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Net Income
Positive Free Cash Flow
Positive 3-Year Average ROE
58/100
Profitability
Score

Cooper Companies Inc's profitability score is 58/100. The higher the profitability score, the more profitable the company is.

COO Solvency Score
Solvency Due Diligence

Cooper Companies Inc's solvency score is 59/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Low D/E
Long-Term Solvency
Short-Term Solvency
59/100
Solvency
Score

Cooper Companies Inc's solvency score is 59/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

COO Price Targets Summary
Cooper Companies Inc

Wall Street analysts forecast COO stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for COO is 107.67 USD with a low forecast of 94.69 USD and a high forecast of 121.8 USD.

Lowest
Price Target
94.69 USD
7% Downside
Average
Price Target
107.67 USD
6% Upside
Highest
Price Target
121.8 USD
20% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

COO Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

COO Price
Cooper Companies Inc

1M 1M
+8%
6M 6M
+28%
1Y 1Y
+12%
3Y 3Y
+6%
5Y 5Y
+37%
10Y 10Y
+198%
Annual Price Range
101.46
52w Low
76.72
52w High
102.77
Price Metrics
Average Annual Return 4.21%
Standard Deviation of Annual Returns 17.28%
Max Drawdown -45%
Shares Statistics
Market Capitalization 20.2B USD
Shares Outstanding 198 756 000
Percentage of Shares Shorted 1.69%

COO Return Decomposition
Main factors of price return

What is price return decomposition?

COO News

Other Videos

Company Profile

Cooper Companies Inc Logo
Cooper Companies Inc

Country

United States of America

Industry

Health Care

Market Cap

20.2B USD

Dividend Yield

0.01%

Description

The Cooper Cos, Inc. operates as a medical device company. The company is headquartered in San Ramon, California and currently employs 12,000 full-time employees. The firm operates through two segments: CooperVision and CooperSurgical. The CooperVision segment is engaged in developing, manufacturing, and marketing a range of products for contact lens wearers, featuring advanced materials and optics. CooperVision designs its products to solve vision challenges such as astigmatism, presbyopia, myopia, ocular dryness, and eye fatigues, with a collection of spherical, toric and multifocal contact lenses. The CooperSurgical segment is focused on advancing the health of women, babies, and families through a diversified portfolio of products and services including medical devices, fertility, diagnostics and contraception. CooperSurgical's products are used in medical office and surgical procedures, primarily by obstetricians/gynecologists (OB/GYN); and fertility products/equipment and genetic testing services used primarily in fertility clinics and laboratories.

Contact

CALIFORNIA
San Ramon
6101 Bollinger Canyon Rd Ste 500
+19254603600.0
https://www.coopercos.com/

IPO

1983-01-21

Employees

12 000

Officers

President, CEO & Non-Independent Director
Mr. Albert G. White III
Executive VP, CFO & Treasurer
Mr. Brian G. Andrews
Executive VP & COO
Mr. Daniel G. McBride Esq.
President of CooperSurgical, Inc.
Ms. Holly R. Sheffield
President of CooperVision, Inc.
Mr. Gerard H. Warner III
Senior VP & Chief Accounting Officer
Mr. Agostino Ricupati
Show More
Vice President of Investor Relations & Risk Management
Mr. Kim Duncan
General Counsel & Corporate Secretary
Mr. Nicholas S. Khadder
Show Less

See Also

Discover More
What is the Intrinsic Value of one COO stock?

The intrinsic value of one COO stock under the Base Case scenario is 55.01 USD.

Is COO stock undervalued or overvalued?

Compared to the current market price of 101.46 USD, Cooper Companies Inc is Overvalued by 46%.